1,365
Views
37
CrossRef citations to date
0
Altmetric
Research Article

Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer

, , , , &
Pages 978-983 | Received 26 May 2010, Accepted 08 Jun 2010, Published online: 13 Sep 2010

References

  • Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43:828–36.
  • Gibbs P, Liney GP, Pickles MD, Zelhof B, Rodrigues G, Turnbull LW. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol 2009;44:572–6.
  • Xu J, Humphrey PA, Kibel AS, Snyder AZ, Narra VR, Ackerman JJ, . Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn Reson Med 2009;61:842–50.
  • Groenendaal G, Moman MR, Korporaal JG, van Diest PJ, van VM, Philippens ME, . Validation of functional imaging with pathology for tumor delineation in the prostate. Radiother Oncol 2010;94:145–50.
  • Le BD. Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed 1995;8:375–86.
  • Hamstra DA, Galban CJ, Meyer CR, Johnson TD, Sundgren PC, Tsien C, . Functional diffusion map as an early imaging biomarker for high-grade glioma: Correlation with conventional radiologic response and overall survival. J Clin Oncol 2008;26:3387–94.
  • Ellingson BM, Malkin MG, Rand SD, Connelly JM, Quinsey C, LaViolette PS, . Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging 2010;31:538–48.
  • Korporaal JG, van den Berg CA, Groenendaal G, Moman MR, van VM, van der Heide UA. The use of probability maps to deal with the uncertainties in prostate cancer delineation. Radiother Oncol 2010;94:168–72.
  • Harry VN, Semple SI, Gilbert FJ, Parkin DE. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 2008;111:213–20.
  • Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: A biomarker for treatment response in oncology. J Clin Oncol 2007;25:4104–9.
  • Nilsen L, Fangberget A, Geier O, Olsen DR, Seierstad T. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Acta Oncol 2010;49:354–60.
  • Song I, Kim CK, Park BK, Park W. Assessment of response to radiotherapy for prostate cancer: Value of diffusion-weighted MRI at 3T. AJR Am J Roentgenol 2010;194: W477–W482.
  • Padhani AR, Khan AA. Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy. Target Oncol 2010;5:39–52.
  • Vandecaveye V, Dirix P, De KF, Op de BK, Vander PV, Roebben I, . Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010 (in press).
  • Tanderup K, Nielsen SK, Nyvang GB, Pedersen EM, Rohl L, Aagaard T, . From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiother Oncol 2010;94:173–80.
  • Haie-Meder C, Pötter R, Van LE, Briot E, De BM, Dimopoulos J, . Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235–45.
  • De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van LE. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 2008;88:217–26.
  • Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:756–64.
  • Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2005;62:901–11.
  • Assenholt MS, Petersen JB, Nielsen SK, Lindegaard JC, Tanderup K. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Acta Oncol 2008;47:1337–43.
  • Dimopoulos JC, Potter R, Lang S, Fidarova E, Georg P, Dorr W, . Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol 2009;93:311–5.
  • Pötter R, Kirisits C, Fidarova EF, Dimopoulos JC, Berger D, Tanderup K, . Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 2008;47:1325–36.
  • Pötter R, Haie-Meder C, Van LE, Barillot I, De BM, Dimopoulos J, . Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67–77.
  • Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O. Apparent diffusion coefficient in cervical cancer of the uterus: Comparison with the normal uterine cervix. Eur Radiol 2005;15:71–8.
  • Payne GS, Schmidt M, Morgan VA, Giles S, Bridges J, Ind T, . Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer. Gynecol Oncol 2010;116:246–52.
  • Charles-Edwards EM, Messiou C, Morgan VA, De Silva SS, McWhinney NA, Katesmark M, . Diffusion-weighted imaging in cervical cancer with an endovaginal technique: Potential value for improving tumor detection in stage Ia and Ib1 disease. Radiology 2008;249:541–50.
  • McVeigh PZ, Syed AM, Milosevic M, Fyles A, Haider MA. Diffusion-weighted MRI in cervical cancer. Eur Radiol 2008;18:1058–64.
  • Kallehauge JF, Tanderup K, Haack S, Nielsen T, Fokdal L, Lindegaard JC, . Apparent diffusion coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: Dependence on b-values used. Acta Oncol 2010 (in press).
  • Sasaki M, Yamada K, Watanabe Y, Matsui M, Ida M, Fujiwara S, . Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: A multivendor, multi-institutional comparison study. Radiology 2008;249:624–30.
  • Ogura A, Hayakawa K, Miyati T, Maeda F. Imaging parameter effects in apparent diffusion coefficient determination of magnetic resonance imaging. Eur J Radiol 2009.
  • Dimopoulos JC, Schirl G, Baldinger A, Helbich TH, Potter R. MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol 2009;185:282–7.
  • Mayr NA, Wang JZ, Zhang D, Grecula JC, Lo SS, Jaroura D, . Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer. Int J Radiat Oncol Biol Phys 2010;77:502–8.
  • Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusional kurtosis imaging: The quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 2005;53:1432–40.
  • Yablonskiy DA, Bretthorst GL, Ackerman JJ. Statistical model for diffusion attenuated MR signal. Magn Reson Med 2003;50:664–9.
  • Ostergaard NK, de Senneville BD, Elstrom UV, Tanderup K, Sorensen TS. Acceleration and validation of optical flow based deformable registration for image-guided radiotherapy. Acta Oncol 2008;47:1286–93.
  • Groenendaal G, van den Berg CA, Korporaal JG, Philippens ME, Luijten PR, van VM, . Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients. Radiother Oncol 2010;95:185–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.